Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lessening Organ Dysfunction with Vitamin C (LOVIT)
2019-003350-80Phase 3Completed
- Sponsor
- Université de Sherbrooke
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis comparing High-dose intravenous vitamin C with Placebo (2 arms). Primary endpoint: Composite of death or persistent organ dysfunction at 28 days. Started Nov 2019; status: completed.
02
Drugs
ascorbic acid
03
Conditions
sepsis
Beyond the preview
Go deeper on 2019-003350-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003350-80.